Roche Reports Mixed Results in Trial of an Alzheimer’s Drug
While the drug, crenezumab, did not slow progression of the disease over all, at the highest doses it seemed to delay a decline in mental ability in patients with mild Alzheimer’s. [Source]
Publication Date:Origin: nytimes.com
Category: Alzheimer's Disease
Topics: Alzheimer’s, patients, ability, mental, decline, delay, seemed, doses, highest, disease, progression, crenezumab, While, Trial, Results, Mixed, Reports, Roche